24 studies found for:    2502
Show Display Options
Rank Status Study
1 Not yet recruiting Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients
Condition: Chagas Disease
Intervention: Drug: Nifurtimox (BAYa2502)
2 Completed Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients
Condition: Chagas Disease
Interventions: Drug: Nifurtimox (BAYa2502) (4 x 30 mg tablet);   Drug: Nifurtimox (BAYa2502) (slurry of 4 x 30 mg tablets in tap water);   Drug: Nifurtimox (BAYa2502) (120 mg tablet)
3 Active, not recruiting Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Hodgkin Lymphoma
Interventions: Drug: Bendamustine Hydrochloride;   Drug: Carboplatin;   Biological: Rituximab;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis
4 Recruiting Radiogenomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
Condition: Lung Cancer
5 Completed
Has Results
A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy
Condition: Moderate to Severe Pain Due to Diabetic Polyneuropathy
Interventions: Drug: Oxycodone Naloxone;   Drug: Placebo tablets
6 Completed Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: COLAL-PRED®;   Drug: Prednisolone
7 Completed Can Structured Education Promote Physical Activity in Those Identified With an Increased Risk of Developing Diabetes
Condition: Prediabetic State
Interventions: Behavioral: PREPARE with pedometer;   Behavioral: PREPARE
8 Completed
Has Results
Irinotecan Study For Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Drug: Irinotecan
9 Completed NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)
Condition: Head and Neck Neoplasms
Intervention: Drug: DOCETAXEL(XRP6976)
10 Completed GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: DOCETAXEL
11 Completed TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian
Condition: Ovarian Neoplasms
Intervention: Drug: Docetaxel
12 Unknown  Methods of Improvement Adherence With Therapy in Ulcerative Colitis.
Condition: Ulcerative Colitis
Intervention: Behavioral: Range of electronic pill dispensers with alarms
13 Completed
Has Results
Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance
Condition: Abdominal Adhesions
Intervention: Device: Transgastric diagnostic peritoneoscopy with laparoscopic assistance
14 Active, not recruiting Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: Ponesimod 10 mg;   Drug: Ponesimod 20 mg;   Drug: Ponesimod 40 mg
15 Completed ACT-128800 in Relapsing-remitting Multiple Sclerosis
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: ACT-128800;   Drug: Placebo
16 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
17 Completed
Has Results
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Condition: Stroke
Interventions: Drug: Aggrenox;   Drug: Clopidogrel placebo;   Drug: Micardis;   Drug: Aggrenox placebo;   Drug: Clopidogrel;   Drug: Micardis placebo
18 Recruiting Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Linagliptin
19 Completed
Has Results
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI 1744);   Drug: Formoterol;   Drug: Placebo
20 Recruiting Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease;   Prodromal Alzheimer's Disease
Interventions: Drug: Verubecestat (Part I and Part II);   Drug: Placebo (Part I);   Drug: Verubecestat (Part II)

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years